Cargando…
SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
BACKGROUND: The effects of atorvastatin on SDF-1α expression under acute myocardial infarction (AMI) are still unclear. Therefore, our present study is to investigate the roles and mechanisms of atorvastatin treatment on SDF-1α expression in rats with AMI. METHODS: Male Sprague–Dawley rats were unde...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533954/ https://www.ncbi.nlm.nih.gov/pubmed/23170833 http://dx.doi.org/10.1186/1423-0127-19-99 |
_version_ | 1782254493525606400 |
---|---|
author | Qiu, Ruofeng Cai, Anping Dong, Yugang Zhou, Yingling Yu, Danqing Huang, Yuli Zheng, Dongdan Rao, Shaoqi Feng, Yingqing Mai, Weiyi |
author_facet | Qiu, Ruofeng Cai, Anping Dong, Yugang Zhou, Yingling Yu, Danqing Huang, Yuli Zheng, Dongdan Rao, Shaoqi Feng, Yingqing Mai, Weiyi |
author_sort | Qiu, Ruofeng |
collection | PubMed |
description | BACKGROUND: The effects of atorvastatin on SDF-1α expression under acute myocardial infarction (AMI) are still unclear. Therefore, our present study is to investigate the roles and mechanisms of atorvastatin treatment on SDF-1α expression in rats with AMI. METHODS: Male Sprague–Dawley rats were underwent permanent coronary artery ligation and randomly assigned into four groups as follow: blank control (B), atorvastatin (A), atorvastatin plus L-NAME (A+L-NAME), and atorvastatin plus AMD3100 (A+AMD3100). Rats underwent similar procedure but without ligation were used as group sham operated (S). Atorvastatin (10mg/Kg/d body weight) was administrated by gavage to rats in three atorvastatin treated groups, and L-NAME (40mg/Kg/d body weight) or AMD3100 (5mg/Kg/d body weight) was given to group A+L-NAME or A+AMD3100, respectively. RESULTS: Comparing with group B, NO production, SDF-1α and CXCR4 expression were significantly up-regulated in three atorvastatin treated groups at the seventh day. However, the increments of SDF-1α and CXCR4 expression in group A+L-NAME were reduced when NO production was inhibited by L-NAME. Anti-inflammatory and anti-apoptotic effects of atorvastatin were offset either by decrease of SDF-1α and CXCR4 expression (by L-NAME) or blockage of SDF-1α coupling with CXCR4 (by AMD3100). Expression of STAT3, a cardioprotective factor mediating SDF-1α/CXCR4 axis induced cardiac protection, was up-regulated most significantly in group A. The effects of atorvastatin therapy on cardiac function were also abrogated either when SDF-1α and CXCR4 expression was diminished or the coupling of SDF-1α with CXCR4 was blocked. CONCLUSION: SDF-1α upregulation by atorvastatin in rats with AMI was, at least partially, via the eNOS/NO dependent pathway, and SDF-1α upregulation and SDF-1α coupling with CXCR4 conferred anti-inflammatory and anti-apoptotic effects under AMI setting which we speculated that ultimately contributed to cardiac function improvement. |
format | Online Article Text |
id | pubmed-3533954 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35339542013-01-07 SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects Qiu, Ruofeng Cai, Anping Dong, Yugang Zhou, Yingling Yu, Danqing Huang, Yuli Zheng, Dongdan Rao, Shaoqi Feng, Yingqing Mai, Weiyi J Biomed Sci Research BACKGROUND: The effects of atorvastatin on SDF-1α expression under acute myocardial infarction (AMI) are still unclear. Therefore, our present study is to investigate the roles and mechanisms of atorvastatin treatment on SDF-1α expression in rats with AMI. METHODS: Male Sprague–Dawley rats were underwent permanent coronary artery ligation and randomly assigned into four groups as follow: blank control (B), atorvastatin (A), atorvastatin plus L-NAME (A+L-NAME), and atorvastatin plus AMD3100 (A+AMD3100). Rats underwent similar procedure but without ligation were used as group sham operated (S). Atorvastatin (10mg/Kg/d body weight) was administrated by gavage to rats in three atorvastatin treated groups, and L-NAME (40mg/Kg/d body weight) or AMD3100 (5mg/Kg/d body weight) was given to group A+L-NAME or A+AMD3100, respectively. RESULTS: Comparing with group B, NO production, SDF-1α and CXCR4 expression were significantly up-regulated in three atorvastatin treated groups at the seventh day. However, the increments of SDF-1α and CXCR4 expression in group A+L-NAME were reduced when NO production was inhibited by L-NAME. Anti-inflammatory and anti-apoptotic effects of atorvastatin were offset either by decrease of SDF-1α and CXCR4 expression (by L-NAME) or blockage of SDF-1α coupling with CXCR4 (by AMD3100). Expression of STAT3, a cardioprotective factor mediating SDF-1α/CXCR4 axis induced cardiac protection, was up-regulated most significantly in group A. The effects of atorvastatin therapy on cardiac function were also abrogated either when SDF-1α and CXCR4 expression was diminished or the coupling of SDF-1α with CXCR4 was blocked. CONCLUSION: SDF-1α upregulation by atorvastatin in rats with AMI was, at least partially, via the eNOS/NO dependent pathway, and SDF-1α upregulation and SDF-1α coupling with CXCR4 conferred anti-inflammatory and anti-apoptotic effects under AMI setting which we speculated that ultimately contributed to cardiac function improvement. BioMed Central 2012-11-21 /pmc/articles/PMC3533954/ /pubmed/23170833 http://dx.doi.org/10.1186/1423-0127-19-99 Text en Copyright ©2012 Qiu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Qiu, Ruofeng Cai, Anping Dong, Yugang Zhou, Yingling Yu, Danqing Huang, Yuli Zheng, Dongdan Rao, Shaoqi Feng, Yingqing Mai, Weiyi SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects |
title | SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects |
title_full | SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects |
title_fullStr | SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects |
title_full_unstemmed | SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects |
title_short | SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects |
title_sort | sdf-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533954/ https://www.ncbi.nlm.nih.gov/pubmed/23170833 http://dx.doi.org/10.1186/1423-0127-19-99 |
work_keys_str_mv | AT qiuruofeng sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects AT caianping sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects AT dongyugang sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects AT zhouyingling sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects AT yudanqing sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects AT huangyuli sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects AT zhengdongdan sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects AT raoshaoqi sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects AT fengyingqing sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects AT maiweiyi sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects |